ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited（ASLN）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · ASLN · 截至 Jun 9, 2026
关键指标
探索 ASLAN Pharmaceuticals Limited 数据
asln stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 4 · 买入占比: 100.0%
竞争对手与同行
asln competitorsASLN
ALBO
CDMO
CMRX
EXAI
HARP股票表现
完整历史关于 ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance pati…
what is aslan pharmaceuticals limited · asln stock overview · aslan pharmaceuticals limited company profile · who is aslan pharmaceuticals limited ceo · asln NASDAQ · aslan pharmaceuticals limited headquarters · aslan pharmaceuticals limited business segments
关于股票概览与关键数据
ASLAN Pharmaceuticals Limited（ASLN）是 Biotechnology 行业的 Healthcare 类公司，于 May 4, 2018 在 NASDAQ 上市。截至最近交易日，ASLN 股价为 $0.60，市值约为 $777.1M。过去12个月累计回报 -96.51%，年初至今回报 -86.36%。
根据 4 位华尔街分析师，ASLAN Pharmaceuticals Limited 股票共识评级为Buy，12个月平均目标价为 $—。2023 财年 ASLAN Pharmaceuticals Limited 营收 $12.0M，净利润 -$44.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。
常见问题
截至最近一个交易日，ASLAN Pharmaceuticals Limited（ASLN）股价为 $0.60，在 NASDAQ 上市，52周区间为 $0.47 – $17.04。